Quantitation of the intensity of CDK8 across duplicate cores from the different ovarian cancer subtypes revealed higher levels of CDK8 in all tumor tissues as compared to benign tissue that comprised a combination of ovary, omentum, and fallopian tube tissues (Figure 1(Ai,Aii)). This evidence concerns the gene CDK8 and neoplasm.